Julio C. Chávez

Moffitt Cancer Center

ORCID: 0000-0002-2045-6238

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 19 papers. Top paper: “Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma”.

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

New England Journal of Medicine(2017)10.1056/nejmoa1707447

N/A

1.3DataRank · unranked

5812 citations

Frederick L. Locke, Nancy L. Bartlett, Lazaros J. Lekakis, David B. Miklos, Caron A. Jacobson +41 more

Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium

Journal of Clinical Oncology(2020)10.1200/jco.19.02104

N/A

1.0DataRank · unranked

800 citations

Michael D. Jain, Lei Feng, Jay Y. Spiegel, Armin Ghobadi, Yi Lin +23 more

Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium

Journal of Clinical Oncology(2024)10.1200/jco.23.02786

N/A

0.650DataRank · unranked

75 citations

Jay Y. Spiegel, Loretta J. Nastoupil, John Tamaresis, Armin Ghobadi, Yi Lin +27 more

Baseline Serum Inflammatory Proteins Predict Poor CAR T Outcomes in Diffuse Large B-cell Lymphoma

Blood Cancer Discovery(2024)10.1158/2643-3230.bcd-23-0056

N/A

0.557DataRank · unranked

40 citations

Sae Bom Lee, Michael D. Jain, Biwei Cao, Xuefeng Wang, Kai Rejeski +28 more

Acute patient‐reported outcomes in B‐cell malignancies treated with axicabtagene ciloleucel

Cancer Medicine(2021)10.1002/cam4.3664

N/A

0.538DataRank · unranked

35 citations

Reena Jayani, Aaron Collier, Nathaly Irizarry‐Arroyo, Yvelise Rodriguez, Michael D. Jain +17 more

Treatment-related outcomes and patterns of relapse in secondary CNS involvement by large B-cell lymphoma

Blood(2026)10.1182/blood.2025031455

N/A

0.241DataRank · unranked

4 citations

Diva Baggio, Sunwoo Han, Paola Ghione, Imran Nizamuddin, Jahanzaib Khwaja +56 more

Prospective Assessment of Quality of Life and Patient-Reported Toxicities Over the First Year After Chimeric Antigen Receptor T-Cell Therapy

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.09.013

N/A

0.241DataRank · unranked

4 citations

Anna Barata, Xiaoyin Li, Nathaly Irizarry‐Arroyo, Michael D. Jain, Taylor Welniak +19 more

Comparison of axicabtagene ciloleucel and tisagenlecleucel patient CAR-T cell products by single-cell RNA sequencing

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-011807

N/A

0.241DataRank · unranked

4 citations

Michael D. Jain, Meghan Menges, Ling Cen, Jerald Noble, Reginald Atkins +20 more

PATIENT‐REPORTED QUALITY OF LIFE (QOL) FOLLOWING TISAGENLECLEUCEL (TISA‐CEL) INFUSION IN ADULT PATIENTS (PTS) WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (R/R FL)

Hematological Oncology(2021)10.1002/hon.178_2880

N/A

0DataRank · unranked

1 citations

Michael Dickinson, Joaquín Martínez‐López, Arne Kolstad, Stephen J. Schuster, Martin Dreyling +29 more

Change in Neurocognitive Performance Among Patients with Non-Hodgkin Lymphoma in the First Year after Chimeric Antigen Receptor T Cell Therapy

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.03.023

N/A

0DataRank · unranked

44 citations

Anna Barata, Jennifer M. Logue, Anuhya Kommalapati, Kelly A. Hyland, Ashley M. Nelson +15 more

Survival trends among patients diagnosed with both melanoma and chronic lymphocytic leukemia.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e19527

N/A

0DataRank · unranked

0 citations

Rossybelle P. Amorrortu, Sandra C. Stewart, Kavita Ghia, Vonetta L. Williams, Vernon K. Sondak +5 more

Bridging therapy with axicabtagene ciloleucel for large B-cell lymphoma: results from the US Lymphoma CAR-T Consortium

Blood Advances(2023)10.1182/bloodadvances.2023011489

N/A

0DataRank · unranked

26 citations

Miriam T. Jacobs, Feng Gao, Loretta J. Nastoupil, Jay Y. Spiegel, Yi Lin +21 more

Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma

Leukemia(2021)10.1038/s41375-021-01193-6

N/A

0DataRank · unranked

83 citations

Luca Castagna, Laura Giordano, Vincent T. Ho, Paolo Corradini, Anna Guidetti +61 more

Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions

Blood(2021)10.1182/blood.2021012888

N/A

0DataRank · unranked

95 citations

Daniel Reed, Ashley McCook, Jeremy Sen, Christian Barlow, Mary‐Kate Malecek +48 more

Incidence and Management of Effusions Before and After CD19-Directed Chimeric Antigen Receptor (CAR) T Cell Therapy in Large B Cell Lymphoma

Transplantation and Cellular Therapy(2020)10.1016/j.jtct.2020.12.025

N/A

0DataRank · unranked

10 citations

Ambuj Kumar, Hamza Hashmi, Franco Garcia, Constantine Logothetis, Alicia Darwin +14 more

The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas

Blood Advances(2024)10.1182/bloodadvances.2024012800

N/A

0DataRank · unranked

4 citations

Fredrik Ellin, Thomas Relander, Miao Cao, Wenrui Li, Qi Long +46 more

Mitigating T-cell mitochondrial dysfunction in CLL to augment CAR T-cell therapy: evaluation in an immunocompetent model

Blood Advances(2025)10.1182/bloodadvances.2024014822

N/A

0DataRank · unranked

12 citations

Nienke B. Goedhart, Helga Simon‐Molas, Melanie Mediavilla-Varela, Angimar Uriepero-Palma, Fleur S. Peters +11 more

Patterns and Predictors of Failure in Recurrent or Refractory Large B-Cell Lymphomas After Chimeric Antigen Receptor T-Cell Therapy

International Journal of Radiation Oncology*Biology*Physics(2021)10.1016/j.ijrobp.2021.06.038

N/A

0DataRank · unranked

53 citations

Timothy J. Robinson, Austin J. Sim, Xuefeng Wang, Biwei Cao, Julio C. Chávez +11 more

Outcomes of CD19 Chimeric Antigen Receptor T Cell Therapy in Patients with Gastrointestinal Tract Involvement of Large B Cell Lymphoma

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.05.018

N/A

0DataRank · unranked

14 citations

Ariel Perez Perez, Christina A. Bachmeier, Rahul Mhaskar, Julio C. Chávez, Bijal Shah +7 more